DETAILED ACTION
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention.
Claims 1-2, 4-5, 7 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Li (CN 113135945 A).
Regarding Claims 1-2, 4-5, 7, Li teaches a material represented by C13 (page 4/9):
PNG
media_image1.png
260
334
media_image1.png
Greyscale
C-13 reads on applicants’ Formula 1 wherein L1 = phenyl, Ring A= bridged cyclohexane; X = N-L2-R3, L2 = phenyl, R3 = tert-butyl; R1 = bridged cyclohexane; R4 = tert-butyl; R2 = H; Ring C and D = phenyl (per claim 1).
C-13 contains two aryl amino groups (per claim 2)
Ring A =
PNG
media_image2.png
60
58
media_image2.png
Greyscale
C and D = phenyl (per claim 4)
R1 = bridged cyclohexane; R4 = tert-butyl (per claim 5)
R3 = tert-butyl (per claim 7)
Regarding Claims 9-10, Li teaches an OLED light-emitting device generally includes: a substrate material, such as glass, metal foil, or polymer film; an anode, such as transparent conductive indium tin oxide; a cathode, such as conductive
aluminum or other metal; and one or more organic semiconductors, such as
an electron injection layer between the light-emitting layer and the cathode,
and a hole injection layer between the light-emitting layer and the anode,
wherein the light-emitting layer contains light-emitting dopants mixed with the
host material to form the light-emitting layer (machine trans paragraph 13). C-23 is used in the light emitting layer (machine trans paragraph 26) (per claims 9-10).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claims 3 and 6 are rejected under 35 U.S.C. 103 as being unpatentable over Li (CN 113135945 A).
Regarding Claims 3 and 6, Li teaches a material represented by C13, above, wherein R2 = H. C-13 is derived from generic I (GI) (abstract):
PNG
media_image3.png
226
412
media_image3.png
Greyscale
GI shows X5 = H which corresponds to applicants’ R2.
PNG
media_image4.png
346
756
media_image4.png
Greyscale
Li teaches a finite set of options for X1-X5 which is independently viewed as functionally independent whereby upon selected gives rise to obvious variants of GI such as C-13.
One such obvious variant reading on the instant limitations is best viewed as a modification of C-13 wherein X5 as H is replaced by a phenyl group resulting in C-13-X5Ph:
PNG
media_image5.png
280
319
media_image5.png
Greyscale
Je teaches various substituents options for R1-R18. Such groups are viewed as functional equivalent substituents which gives rise to obvious variants based on generic Compound 1a.
It would have been obvious to one of ordinary skill in the art before the filing date of the invention to have made a variety of derivatives of GI by selecting various functional equivalent substituents which would have included the above variant which reads on the instant limitations, absent unexpected results (per claim 6).
C-13-X5Ph reads on
PNG
media_image6.png
174
210
media_image6.png
Greyscale
wherein L1 = phenyl, Ring A= bridged cyclohexane; X = N-L2-R3, L2 = phenyl, R3 = tert-butyl; R1 = bridged cyclohexane; R4 = tert-butyl; R2 = phenyl; Ring C and D = phenyl (per claim 3).
Allowable Subject Matter
Claim 8 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.
A comprehensive search did not show the claimed compounds.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to GREGORY D CLARK whose telephone number is (571)270-7087. The examiner can normally be reached on 8AM-4PM M-F.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Chriss can be reached on 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/GREGORY D CLARK/Primary Examiner, Art Unit 1786
